LIFEVANTAGE CORP Other Current Liabilities
LIFEVANTAGE CORP (LFVN) had Other Current Liabilities of $90.69 thousand as of 2012-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2012-05-15
- 2012-03-31: Other Liabilities, Current $90.69K.
- 2011-06-30: Other Liabilities, Current $69.89K.
| Period end | Other Liabilities, Current |
|---|---|
| 2012-03-31 | $90.69K 10-Q · filed 2012-05-15 |
| 2011-06-30 | $69.89K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |